Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat + Exemestane in HR+ Advanced Breast Cancer (EOC103A3101)
NCT03538171Phase 3Unknown
- Sponsor
- EOC Pharma
- Start
- May 2018
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of entinostat in breast cancer, sponsored by EOC Pharma. Status: unknown.
02
Drugs
entinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03538171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03538171.